DUBLIN--(BUSINESS WIRE)--The "Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's ...
Evidence has suggested free fatty acid receptor 1 (FFAR1), also known as GPR40, as a promising therapeutic target in the treatment of type 2 diabetes, since its activation in pancreatic β cells ...
Free-fatty acid receptor 1 (FFAR1) activation has been found to be a new potential therapeutic target for insulin secretion amongst type-2 diabetics New drug targets have been under research in order ...
HealthDay News — An investigative drug known as TAK-875 increased insulin secretion without raising hypoglycemia risk in patients with type 2 diabetes who did not respond to diet modification or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results